<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02803281</url>
  </required_header>
  <id_info>
    <org_study_id>15-9170</org_study_id>
    <nct_id>NCT02803281</nct_id>
  </id_info>
  <brief_title>Assessment of Patient Frailty Prior to Thoracic Surgery</brief_title>
  <official_title>Assessment of Patient Frailty Prior to Thoracic Surgery: A Feasibility Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Health Network, Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Health Network, Toronto</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Determine the feasibility of assessment of measures of frailty and determine if these
      measures provide a clinically important contribution of risk assessment in a population of
      patients undergoing major thoracic surgery for lung or esophageal cancer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Both gastro-esophageal and lung cancers are major causes of morbidity and mortality
      worldwide. In Canada the incidence for Esophageal Adenocarcinoma has doubled in the last two
      decades, while lung cancer is the leading cause of cancer death. Surgery is a treatment
      option for these patients; however, esophagectomy in particular, is associated with
      significant morbidity, mortality and adverse effect on quality of life. Despite satisfactory
      standard preoperative testing to evaluate risk for surgery, some patients experience
      morbidity and never recover fully from surgery. Frailty assessment may offer a more sensitive
      measure of a patient's physiologic reserve, which may allow identification of patients who
      are poor candidates for surgery. There is a lack of consensus of how best to assess frailty
      prior to surgery. This study aims to analyze frailty assessment as a tool for patient
      selection for surgery.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>August 2015</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Feasibility Assessment</measure>
    <time_frame>2 years</time_frame>
    <description>Determine the feasibility of assessment of measures of frailty and determine if these measures provide a clinically important contribution of risk assessment in a population of patients undergoing major thoracic surgery for lung or esophageal cancer.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Lung Cancer</condition>
  <condition>Esophageal Cancer</condition>
  <arm_group>
    <arm_group_label>Lung Cancer - Frialty Assessment</arm_group_label>
    <description>Patients who will undergo surgery for lung cancer</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Esophageal Cancer - Frailty Assessment</arm_group_label>
    <description>Patients who will undergo esophagectomy for esophageal cancer</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Frailty Assessment</intervention_name>
    <description>Various physiologic and frailty assessment tests</description>
    <arm_group_label>Lung Cancer - Frialty Assessment</arm_group_label>
    <arm_group_label>Esophageal Cancer - Frailty Assessment</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Cancer Patients - Lung or Esophageal
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with Esophageal or Lung Cancer who will undergo resectional surgery.

        Exclusion Criteria:

          -  Patients undergoing diagnostic or staging procedures or pulmonary wedge excisions will
             be excluded.

          -  Patients unable to give informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Health Network</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 2C4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <link>
    <url>http://www.cancer.ca</url>
    <description>Canadian Cancer Statistics 2010</description>
  </link>
  <reference>
    <citation>Hodari A, Hammoud ZT, Borgi JF, Tsiouris A, Rubinfeld IS. Assessment of morbidity and mortality after esophagectomy using a modified frailty index. Ann Thorac Surg. 2013 Oct;96(4):1240-5. doi: 10.1016/j.athoracsur.2013.05.051. Epub 2013 Jul 31.</citation>
    <PMID>23915593</PMID>
  </reference>
  <reference>
    <citation>Talsma AK, Damhuis RA, Steyerberg EW, Rosman C, van Lanschot JJ, Wijnhoven BP. Determinants of improved survival after oesophagectomy for cancer. Br J Surg. 2015 May;102(6):668-75. doi: 10.1002/bjs.9792. Epub 2015 Mar 18.</citation>
    <PMID>25787705</PMID>
  </reference>
  <reference>
    <citation>Makary MA, Segev DL, Pronovost PJ, Syin D, Bandeen-Roche K, Patel P, Takenaga R, Devgan L, Holzmueller CG, Tian J, Fried LP. Frailty as a predictor of surgical outcomes in older patients. J Am Coll Surg. 2010 Jun;210(6):901-8. doi: 10.1016/j.jamcollsurg.2010.01.028. Epub 2010 Apr 28.</citation>
    <PMID>20510798</PMID>
  </reference>
  <reference>
    <citation>Robinson TN, Eiseman B, Wallace JI, Church SD, McFann KK, Pfister SM, Sharp TJ, Moss M. Redefining geriatric preoperative assessment using frailty, disability and co-morbidity. Ann Surg. 2009 Sep;250(3):449-55. doi: 10.1097/SLA.0b013e3181b45598.</citation>
    <PMID>19730176</PMID>
  </reference>
  <reference>
    <citation>Chen CH, Ho-Chang, Huang YZ, Hung TT. Hand-grip strength is a simple and effective outcome predictor in esophageal cancer following esophagectomy with reconstruction: a prospective study. J Cardiothorac Surg. 2011 Aug 15;6:98. doi: 10.1186/1749-8090-6-98.</citation>
    <PMID>21843340</PMID>
  </reference>
  <reference>
    <citation>Yano Y, Inokuchi T, Kario K. Walking speed is a useful marker of frailty in older persons. JAMA Intern Med. 2013 Feb 25;173(4):325-6. doi: 10.1001/jamainternmed.2013.1629.</citation>
    <PMID>23440240</PMID>
  </reference>
  <reference>
    <citation>Fritz S, Lusardi M. White paper: &quot;walking speed: the sixth vital sign&quot;. J Geriatr Phys Ther. 2009;32(2):46-9. Erratum in: J Geriatr Phys Ther. 2009;32(3):110.</citation>
    <PMID>20039582</PMID>
  </reference>
  <reference>
    <citation>Roberts HC, Denison HJ, Martin HJ, Patel HP, Syddall H, Cooper C, Sayer AA. A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. Age Ageing. 2011 Jul;40(4):423-9. doi: 10.1093/ageing/afr051. Epub 2011 May 30. Review.</citation>
    <PMID>21624928</PMID>
  </reference>
  <reference>
    <citation>Sheetz KH, Zhao L, Holcombe SA, Wang SC, Reddy RM, Lin J, Orringer MB, Chang AC. Decreased core muscle size is associated with worse patient survival following esophagectomy for cancer. Dis Esophagus. 2013 Sep-Oct;26(7):716-22. doi: 10.1111/dote.12020. Epub 2013 Jan 25.</citation>
    <PMID>23350746</PMID>
  </reference>
  <reference>
    <citation>Rogalla P, Meiri N, Hoksch B, Boeing H, Hamm B. Low-dose spiral computed tomography for measuring abdominal fat volume and distribution in a clinical setting. Eur J Clin Nutr. 1998 Aug;52(8):597-602.</citation>
    <PMID>9725661</PMID>
  </reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 14, 2016</study_first_submitted>
  <study_first_submitted_qc>June 14, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 16, 2016</study_first_posted>
  <last_update_submitted>January 3, 2018</last_update_submitted>
  <last_update_submitted_qc>January 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 5, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Esophageal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

